focus -WSS

focus

author：explore 2025-09-29 01:08:53 - browse：599

Judge's gavel — Legal experts unpacked the pharmaceutical industry's scattershot approach to challenging Medicare's new power to negotiate drug prices. Adobe

WASHINGTON — The pharmaceutical industry has been filing a lawsuit here, there, and pretty much everywhere.

Drugmakers lost a two-decade long lobbying fight in Congress last summer when Democrats gave Medicare more power to choose what it pays for prescription drugs. Now, they’re taking their battle to the courts.

Merck filed suit in the District of Columbia. Bristol Myers Squibb filed in New Jersey. The Chamber of Commerce filed in Ohio. PhRMA filed in Texas. And there’s no reason to believe the barrage of lawsuits will stop anytime soon.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Deposition: Sackler embraced plan to conceal OxyContin’s strength

explore

WSS

Report captures long Covid’s disabling effects and policy challenges

Pharma companies must ensure equitable access to obesity drugs

Cheap, fast test for Zika and dengue could cost just $1

How faith leaders like me can help address America's obesity epidemic

Stephen Quake on the Chan Zuckerberg quest to conquer disease

Cigna wins case to block Amy Bricker's move to CVS

leisure time

focus

hotspot

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Violet CEO on training clinicians to promote more inclusive care

BioMarin wins approval for gene therapy to treat hemophilia A

Teladoc has a new CEO, but challenges remain the same

Walensky prepares to leave CDC — and Congress — behind

Cheap, fast test for Zika and dengue could cost just $1

Medical leaders decry Supreme Court decision on affirmative action

Readers discuss the intersection of pregnancy and addiction

Wildfire smoke exposes gaps in outdoor worker protections

Stephen Quake on the Chan Zuckerberg quest to conquer disease

focus

Pharma companies must ensure equitable access to obesity drugs

Why health care costs have stayed mostly flat since 2010

Report captures long Covid’s disabling effects and policy challenges

New report analyzes digital physical therapy solutions' effectiveness

Hospitals owned by private equity see complications spike 25%

NIH tests clinical research in primary care with $30 million program

focus

explore

explore

leisure time